Abstract
Women are disproportionately at risk of acquiring HIV in East and Southern Africa, despite global declines in incidence. Female-initiated HIV prevention methods, like the dapivirine vaginal ring, are needed to end the HIV epidemic. In-depth interviews and focus groups retrospectively explored peer influence on acceptability of and adherence to the ring during the ASPIRE trial, a phase III placebo-controlled trial. Results were analyzed using an inductive analytic approach. Study participants (peers) of all ages and adherence groups developed important interpersonal connections and reported being more open and honest with each other than with external peers or study staff. Study peers who knew each other prior to joining appeared to have a stronger influence on each other’s adherence than peers who met in the study. External peers provided primarily negative input about the ring and study, which sometimes led to ring removals. Peers’ influence on each other’s behavior in both prosocial and detrimental manners could have repercussions on adherence to a biomedical intervention, and consequently, individual disease risk and clinical trial outcomes. Future ring demonstration and implementation studies could use peer networks to intentionally influence uptake and adherence to the ring.
Similar content being viewed by others
References
UNAIDS. Global HIV & AIDS Statistics—2018 fact sheet: UNAIDS;2018.
O'Leary A. Women and HIV in the twenty-first century: how can we reach the UN 2030 goal? AIDS Educ Prev. 2018;30(3):213–24.
Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013;63:S122–S129129.
Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.
Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.
Celum CL, Delany S, Baeten JM, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22(Suppl 4):e25298.
Amico KR, Mansoor LE, Corneli A, Torjesen K, van der Straten A. Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS Behav. 2013;17(6):2143–55.
Corneli AL, McKenna K, Headley J, et al. A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa. J Int AIDS Soc. 2014;17(3S2):19152.
van der Straten A, Montgomery ET, Musara P, et al. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015;29(16):2161–71.
Montgomery ET, Mensch B, Musara P, et al. Misreporting of product adherence in the MTN-003/VOICE trial for HIV prevention in Africa: participants' explanations for dishonesty. AIDS Behav. 2017;21(2):481–91.
van der Straten A, Stadler J, Montgomery E, et al. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.
Reid A. More investment needed in developing female-controlled HIV prevention options: UNAIDS; 2016.
van de Wijgert J. Working towards HIV prevention choices for women. The lancet. 2018;5(2):e60–e61.
AVAC. Tracking the fast-changing status of PrEP around the world. 2018. https://www.avac.org/blog/tracking-prep-status. Accessed 12 Nov 2018
Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.
Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis. 2012;25(1):51–7.
Seltzer H, Solai, L. IPM’s Application for dapivirine vaginal ring for reducing HIV risk in women now under review by european medicines agency: international partnership for microbicides; 2017.
Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121–32.
Nel A, Bekker L-G, Bukusi E, et al. Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa. PLoS ONE. 2016;11(3):e0147743.
Brown E, Palanee-Philips T, Marzinke M, et al. Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection. Paper presented at Journal of the International Aids Society; 2016.
Montgomery ET, van der Straten A, Chitukuta M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. Aids. 2017;31(8):1159–67.
Montgomery ET, Stadler J, Naidoo S, et al. Reasons for nonadherence to the dapivirine vaginal ring. Aids. 2018;32(11):1517–25.
Albert D, Chein J, Steinberg L. Peer influences on adolescent decision making. Curr Directions Psychol Sci. 2013;22(2):114–20.
Okonkwo PI, Fatusi AO, Ilika AL. Perception of peers' behaviour regarding sexual health decision making among female undergraduates in Anambra State. Nigeria. Afr Health Sci. 2005;5(2):107–13.
Tome G, Matos M, Simoes C, Diniz JA, Camacho I. How can peer group influence the behavior of adolescents: explanatory model. Glob J Health Sci. 2012;4(2):26–35.
Neary J, Wagner AD, Mugo C, et al. Influence and involvement of support people in adolescent and young adult HIV testing. AIDS Care. 2019;31(1):105–12.
Kanda L, Mash R. Reasons for inconsistent condom use by young adults in Mahalapye, Botswana. Afr J Primary Health Care Fam Med. 2018;10(1):e1–e7.
Chitukuta M, Duby Z, Katz A, et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Cult Health Sex. 2019;21(11):1209–24.
Duby Z, Katz A, Musara P, et al. "The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa. Women Health. 2019;60(1):72–86.
Duby Z, Katz AWK, Browne EN, et al. Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav; 2019.
Pleasants E, Tauya T, Reddy K, et al. Relationship type and use of the vaginal ring for HIV-1 prevention in the MTN 020/ASPIRE trial. AIDS Behav; 2019.
Laborde ND, Pleasants E, Reddy K, et al. Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex. AIDS Behav. 2018;22(2):437–46.
Palanee-Phillips T, Schwartz K, Brown ER, et al. Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention. PLoS ONE. 2015;10(6):e0128857.
Schwartz K, Ndase P, Torjesen K, et al. Supporting participant adherence through structured engagement activities in the MTN-020 (ASPIRE) trial. AIDS Res Hum Retroviruses. 2014;30(S1):A80–A8080.
Fearon E, Wiggins RD, Pettifor AE, Hargreaves JR. Is the sexual behaviour of young people in sub-Saharan Africa influenced by their peers? A systematic review. Soc Sci Med. 2015;146:62–74.
Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–46.
Katz J. Analytic Induction. In: Smelser NJ, Baltes PB, editors. International encyclopedia of the social & behavioral sciences. Oxford: Pergamon; 2001. p. 480–484.
Bhattacharya K. Fundamentals of qualitative research: a practical guide. London: Routledge; 2017.
Magazi B, Stadler J, Delany-Moretlwe S, et al. Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg South Africa. BMC Women's Health. 2014;14:88–88.
van der Straten A, Browne EN, Shapley-Quinn MK, et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81(3):304–10.
Ramchand R, Ahluwalia SC, Xenakis L, Apaydin E, Raaen L, Grimm G. A systematic review of peer-supported interventions for health promotion and disease prevention. Prev Med. 2017;101:156–70.
Morar NS, Naidoo S, Goolam A, Ramjee G. Research participants' skills development as HIV prevention peer educators in their communities. J Health Psychol. 2018;23(10):1343–9.
Naidoo S, Morar NS, Ramjee G. Participants as community-based peer educators: impact on a clinical trial site in KwaZulu-Natal. S Afr J Sci. 2013;109(7–8):01–5.
Aronson E. The social animal. New York: Worth Publishers; 2004.
Hocevar KP, Metzger M, Flanagin AJ. Source credibility, expertise, and trust in health and risk messaging. Oxford: Oxford University Press; 2017.
Anderson N, Steinauer J, Valente T, Koblentz J, Dehlendorf C. Women's social communication about IUDs: a qualitative analysis. Perspect Sex Reprod Health. 2014;46(3):141–8.
Hoopes AJ, Gilmore K, Cady J, Akers AY, Ahrens KR. A qualitative study of factors that influence contraceptive choice among adolescent school-based health center patients. J Pediatr Adolesc Gynecol. 2016;29(3):259–64.
Yee L, Simon M. The role of the social network in contraceptive decision-making among young, African American and Latina women. J Adolesc health. 2010;47(4):374–80.
Oster E, Thornton R. Determinants of technology adoption: peer effects in menstrual cup take-up. J Eur Econ Assoc. 2012;10(6):1263–93.
Kincaid DL. Social networks, ideation, and contraceptive behavior in Bangladesh: a longitudinal analysis. Soc Sci Med. 2000;50(2):215–31.
Beniamino C, Holly S. Social norms and adolescents' sexual health: an introduction for practitioners working in low and mid-income African countries. Afr J Reprod Health. 2018;22(1):38–46.
Closson K, Dietrich JJ, Lachowsky NJ, et al. Sexual self-efficacy and gender: a review of condom use and sexual negotiation among young men and women in sub-saharan Africa. J Sex Res. 2018;55(4–5):522–39.
Romer D, Black M, Ricardo I, et al. Social influences on the sexual behavior of youth at risk for HIV exposure. Am J Public Health. 1994;84(6):977–85.
Kim J. The effect of peers on HIV infection expectations among Malawian adolescents: using an instrumental variables/school fixed effect approach. Soc Sci Med. 1982;2016(152):61–9.
Ball K, Jeffery RW, Abbott G, McNaughton SA, Crawford D. Is healthy behavior contagious: associations of social norms with physical activity and healthy eating. Int J Behav Nutr Phys activity. 2010;7:86–86.
Sheehan DM, Miller RP, Trepka MJ, Smith LR, Latkin C. Role of social network sexual norms and behaviors on the HIV sexual risk behaviors of people who inject drugs in HPTN 037. AIDS Behav. 2019;23(6):1604–11.
Latkin CA, Knowlton AR. Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care. 2005;17(Suppl 1):S102–113.
Berkowitz AD. The social norms approach: theory, research, and annotated bibliography. 2004.
Acknowledgements
We would like to thank AHA participants for their contribution to this research. The Microbicide Trials Network (MTN) leadership and operating center, FHI 360, and MTN-032 Protocol study team members are acknowledged as critical in the development, implementation, and/or analysis of this study. The full MTN-032 study team can be viewed at https://mtnstopshiv.org/research/studies/mtn-032. This paper benefited greatly from the contributions of Ariane van der Straten for review of and contributions to earlier versions of this manuscript. The study was designed and implemented by the MTN funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Katz, A.W.K., Naidoo, K., Reddy, K. et al. The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants’ Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 24, 2387–2399 (2020). https://doi.org/10.1007/s10461-020-02799-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-020-02799-0